Search results for "ADENOCARCINOMA"

showing 10 items of 589 documents

Patterns of DNA-ploidy in operable colorectal carcinoma: A prospective study of 100 cases

1991

A prospective study of cellular DNA content was made by means of flow cytometry in a nonconsecutive series of 100 patients undergoing surgery for primary colorectal adenocarcinoma. DNA-aneuploidy was present in 80% of cases (80/100); 39% of these were multiclonal (31/80). There was no significant correlation between DNA-ploidy and the clinical and pathological features examined, except for the primary tumor site (right colon vs. left colon vs. rectum: P less than 0.001). After a minimum follow-up of 30 months, out of 40 patients with no local invasion and/or distant metastases, 100% (9/9) of those with DNA-diploid neoplasias showed no signs of disease relapse, vs. 55% (17/31) of the DNA-ane…

AdultMaleOncologymedicine.medical_specialtyColorectal cancerAneuploidyRectumAdenocarcinomaGastroenterologyInternal medicinemedicineHumansProspective StudiesProspective cohort studyPathologicalDna ploidyAgedNeoplasm StagingAged 80 and overChi-Square DistributionPloidiesbusiness.industryDNA NeoplasmGeneral MedicineMiddle AgedPrognosismedicine.diseasePrimary tumorSurvival Ratemedicine.anatomical_structureOncologyAdenocarcinomaFemaleSurgeryColorectal NeoplasmsbusinessJournal of Surgical Oncology
researchProduct

Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicente…

2006

This study was designed to evaluate the efficacy and safety of irinotecan/cetuximab administered as third- or fourth-line therapy in a retrospective series of patients with metastatic colorectal cancer refractory to oxaliplatin and irinotecan. Patients and Methods: Most patients (90%) had been previously treated with adjuvant 5-fluorouracil/leucovorin, and all had received oxaliplatin-based regimens before receiving irinotecan- based second-line treatment. Sixty patients with irinotecan-refractory colorectal cancer received a regimen comprising weekly irinotecan 120 mg/m 2 as a 1-hour intravenous infusion and cetuximab 400 mg/m 2 infused over 2 hours as the initial dose and 250 mg/m 2 infus…

AdultMaleOncologymedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsSettore MED/06 - Oncologia MedicaColorectal cancermedicine.medical_treatmentCetuximabAdenocarcinomaAntibodies Monoclonal HumanizedIrinotecanDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasm MetastasisSurvival analysisAgedAged 80 and overChemotherapyCetuximabPerformance statusbusiness.industryGastroenterologyAntibodies MonoclonalMiddle Agedmedicine.diseaseSurvival Analysisdigestive system diseasesOxaliplatinErbB ReceptorsIrinotecanSettore MED/18 - Chirurgia GeneraleRegimenOncologyCamptothecinFemaleEpidermal growth factor receptor Oxaliplatin Vascular endothelial growth factorColorectal Neoplasmsbusinessmedicine.drugClinical Colorectal Cancer
researchProduct

Metastatic carcinoma of the oral region: An analysis of 21 cases

2017

Background Metastatic carcinoma to the jaws and oral region are very rare, representing less than 1% of all oral tumors. Unfortunately, oral metastasis is usually manifestation of an advanced stage of primary cancer, and indicates widespread disease and poor prognosis. Material and Methods In this retrospective study, a total of 2039 patients with history of oral malignant tumor between 1980 and 2012 at Seoul National University Dental Hospital were evaluated. We analyzed the dental and medical records, and histopathological database of 2039 patients to assess the prevalence of oral metastasis of carcinoma in terms of sex and age, as well as, the most common origin of primary cancer, and pr…

AdultMaleOncologymedicine.medical_specialtyMetastatic carcinomaMetastasis03 medical and health sciences0302 clinical medicineInternal medicineBiopsymedicineCarcinomaHumansGeneral DentistryAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryResearchMedical recordRetrospective cohort study030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseasestomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisHepatocellular carcinomaUNESCO::CIENCIAS MÉDICASAdenocarcinomaFemaleMouth NeoplasmsSurgeryRadiologyOral SurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types.

2009

Cancer of the salivary gland is one of the common cancers in the head and the neck regions. This type of cancer develops in the minor and the major salivary glands, and it sometimes metastasizes to other organs, particularly the lung. Morphologic mimicry and similarity in the expression of steroid hormone receptors between salivary gland tumors and breast tumors are well-known phenomena and are occasionally debated in the field of surgical pathology. The expression of sex hormone receptors in some tumors suggests a role for these receptors in tumor pathogenesis and therapy. Previous studies of the expression of estrogens and progesterone receptors in salivary gland tumors have reported conf…

AdultMalePathologymedicine.medical_specialtyAdolescentmedicine.medical_treatmentAdenoma PleomorphicAdenocarcinomaPleomorphic adenomaNeoplasms Multiple PrimaryMajor Salivary GlandProgesterone receptormedicineHumansReceptorGeneral DentistryAgedAged 80 and overbusiness.industrySex hormone receptorMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Salivary Gland NeoplasmsImmunohistochemistrySteroid hormoneCarcinoma ex pleomorphic adenomaOtorhinolaryngologyReceptors EstrogenUNESCO::CIENCIAS MÉDICASAdenocarcinomaSurgeryFemalebusinessReceptors ProgesteroneMedicina oral, patologia oral y cirugia bucal
researchProduct

Oncogene overexpression in non-small-cell lung cancer tissue: prevalence and clinicopathological significance.

1994

In contrast to small-cell lung cancer, few data are available on the role of oncogene overexpression in non-small-cell lung cancers (NSCLC). To determine the prevalence and extent of the transcriptional activation of cancer genes in NSCLC we investigated the level of mRNA of the three important cellular oncogenes — erbB2, Ki-ras, and c-myc — in 39 surgically or endoscopically obtained tumor samples and 24 samples of normal bronchopulmonary tissue taken from the same patients. Tissue RNA was prepared and the specific mRNA analyzed by the highly sensitive nuclease S1 protection assay. Oncogene mRNA in the tumors was quantified by comparison with the homogeneously weak signals in normal lung t…

AdultMalePathologymedicine.medical_specialtyLung NeoplasmsAdolescentBiologyCarcinoma Non-Small-Cell LungDrug DiscoveryGene expressionmedicineCarcinomaHumansLung cancerGenetics (clinical)AgedAged 80 and overMessenger RNAOncogeneCancerOncogenesMiddle Agedmedicine.diseaseMolecular medicineGene Expression Regulation NeoplasticCancer researchMolecular MedicineAdenocarcinomaFemaleThe Clinical investigator
researchProduct

Mammary Analogue Secretory Carcinoma (MASC) of salivary gland in four Mexican patients.

2014

The Clinco-pathological, immunohistochemical and molecular findings of four cases of Mammary Analogue Secretory Carcinoma (MASC) of salivary glands found in Mexico are described. The cases were extracted from 253 salivary gland tumors from a single institution in Mexico City. The 85 candidates for initial selection were: low grade mucoepidermoid carcinoma (MEC) (N=70 ), acinic cell cancinoma (AciCC) (N=14), papillary cystadenocarcinoma (N=1), and adenocarcinoma NOS (N=0). Tumors with some histological features consistent with MASC (N= 17, 6.7%) were studied by immunohistochemistry for mammaglobin, STAT5, and S-100 protein and four cases were positive (1.5%), thus the diagnosis of MASC was e…

AdultMalePathologymedicine.medical_specialtyOdontologíaAcinic cell carcinomaMammaglobinPapillary CystadenocarcinomaMucoepidermoid carcinomaMajor Salivary GlandmedicineHumansMexicoGeneral DentistryLymph nodeRetrospective StudiesAged 80 and overOral Medicine and PathologybiologySalivary glandbusiness.industryResearchMiddle AgedSalivary Gland Neoplasms:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASbiology.proteinFemaleSurgeryMammary Analogue Secretory CarcinomabusinessSecretory Breast CarcinomaMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Cutaneous dermal non-neural granular cell tumor is a granular cell dermal root sheath fibroma

2017

Dermal non-neural granular cell tumor (NNGCT) was first described in 1991 as an S100-negative polypoid non-melanocytic tumor. Although originally introduced in the literature as a primary cutaneous tumor, it was later emphasized that such qualification could not be held until the line of differentiation was clarified. It was also demonstrated that not all cases were polypoid. In the current study we try to further characterize this entity by presenting 5 cases of NNGCT. As expected, not all of them were polypoid. The ages of the patients varied from 10 to 43 (mean age 22). They all were composed of S100-negative granular cells with variable atypia and mitotic figures. None of them recurred …

AdultMalePathologymedicine.medical_specialtySkin NeoplasmsHistologyAdolescentAntigens Differentiation MyelomonocyticFibromaDermatologyRoot sheathAdenocarcinomaPathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAntigens CDBiopsymedicineAtypiaHumansChildGranular cell tumorintegumentary systemmedicine.diagnostic_testbusiness.industryArrector pili muscleHair folliclemedicine.diseaseNeoplasm Proteinsmedicine.anatomical_structure030220 oncology & carcinogenesisImmunohistochemistryFemaleNeprilysinFibromabusinessHair FollicleJournal of Cutaneous Pathology
researchProduct

A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer

2005

A group of 103 sicilian patients with hereditary and familiar breast and/or ovarian cancer were screened for Breast Cancer 1 gene (BRCA1) mutations by direct sequencing PCR products spanning the coding region and partial intronic regions of the BRCA1 gene. In this study, we report a new germline mutation in BRCA1 gene, not previously reported in the BIC database, in a woman with ovarian cancer at 46 years old. Mother's proband has been diagnosed the same histotype of ovarian cancer at 42 age. The mutational analyses that shown a 4843delC frameshift mutation in exon 16 of BRCA1 gene was extended to other family members including the proband's brother and her two sons. Direct automatic sequen…

AdultMaleProbandcongenital hereditary and neonatal diseases and abnormalitiesCancer Researchendocrine system diseasesGenetic counselingCystadenocarcinomaGenes BRCA1BiologyFrameshift mutationExonGermline mutationBreast cancermedicineHumansGenetic Predisposition to DiseaseFrameshift MutationSicilyGerm-Line MutationOvarian NeoplasmsBRCA1 Direct automatic sequencing Germline mutation Ovarian cancerGeneticsMiddle Agedmedicine.diseasePedigreeOncologyMutation (genetic algorithm)Cancer researchFemaleOvarian cancerBreast Cancer Research and Treatment
researchProduct

BRAF(V600E) mutation influences hypoxia-inducible factor-1alpha expression levels in papillary thyroid cancer

2010

Abstract Hypoxia-inducible factor-1alpha is found frequently overexpressed in solid tumors cells, exerting an important role in angiogenesis, glucose metabolism, cell proliferation, survival and invasion. In thyroid carcinomas, hypoxia-inducible factor-1alpha expression was found increased in differentiated, poorly differentiated, medullary and anaplastic variants. Hypoxia represents the principal stimulus responsible for hypoxia-inducible factor-1alpha induction. Other nonhypoxic stimuli increase hypoxia-inducible factor-1alpha synthesis through the activation of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in a cell-type-specific manner. We have previously s…

AdultMaleProto-Oncogene Proteins B-rafAdolescentSettore BIO/11 - Biologia MolecolareSettore MED/08 - Anatomia PatologicaTransfectionhypoxia mutation carcinomaMixed Function OxygenasesSettore MED/13 - EndocrinologiaYoung AdultCell Line TumorBiomarkers TumorHumansGene SilencingThyroid NeoplasmsRNA Small InterferingAgedMiddle AgedGene Expression Regulation NeoplasticRepressor ProteinsAdenocarcinoma PapillaryGene Knockdown TechniquesMutationThyroidectomyFemale
researchProduct

Papillary thyroid cancer incidence in the volcanic area of Sicily.

2009

Abstract BACKGROUND: The steadily increasing incidence of thyroid cancer has been attributed mostly to more sensitive thyroid nodule screening. However, various environmental factors, such as those associated with volcanic areas, cannot be excluded as risk factors. We evaluated thyroid cancer incidence in Sicily, which has a homogenous population and a province (Catania) that includes the Mt Etna volcanic area. METHODS: In a register-based epidemiological survey, we collected all incident thyroid cancers in Sicily from January 1, 2002, through December 31, 2004. The age-standardized incidence rate for the world population (ASR(w)) was calculated and expressed as the number of thyroid cancer…

AdultMaleProto-Oncogene Proteins B-rafCancer Researchmedicine.medical_specialtyPathologyAdolescentPopulationPrevalenceVolcanic EruptionsThyroid CancerRisk AssessmentSettore MED/13 - EndocrinologiaPapillary thyroid cancerThyroid cancer environmental factors SicilyYoung AdultAge DistributionVolcanoes and Thyroid CancerRisk FactorsEpidemiologyAdenocarcinoma FollicularmedicineHumansEnvironment and Thyroid CancerRegistriesThyroid NeoplasmsSex DistributioneducationThyroid cancerSicilyAgedAged 80 and overeducation.field_of_studyObstetricsbusiness.industryIncidence (epidemiology)IncidenceThyroidCancerEnvironmental ExposureMiddle Agedmedicine.diseaseCarcinoma Papillarymedicine.anatomical_structureOncologyCarcinoma MedullaryMutationFemalebusinessJournal of the National Cancer Institute
researchProduct